The WACC of Neoleukin Therapeutics Inc (NLTX) is 11.5%.
| Range | Selected | |
| Cost of equity | 9.90% - 13.30% | 11.60% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 9.8% - 13.2% | 11.5% |
| Category | Low | High |
| Long-term bond rate | 4.2% | 4.7% |
| Equity market risk premium | 5.0% | 6.0% |
| Adjusted beta | 1.14 | 1.35 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 9.90% | 13.30% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.01 | 0.01 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 9.8% | 13.2% |
| Selected WACC | 11.5% | |